Prescriber's Letter | Unbiased Medication Updates & CME

January 2026 Issue

Address New GLP-1 Agonist Side Effect Concerns

Patients are asking if recent side effect claims with GLP-1 agonists (semaglutide, etc) are true...

Resources

Chart: GLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison Chart
Chart: Treatment and Prevention of Hair Loss
FAQ: Managing Erectile Dysfunction
Chart: Perioperative Management of Diabetes
Toolbox: Resources for Discussing Medical Misinformation

Point Out Caveats With Direct-to-Consumer Meds

More drug companies and third-party platforms are selling Rx meds directly to patients...

Elinzanetant: Emerging Therapy for Menopausal Hot Flashes

Rx elinzanetant (Lynkuet) is now approved and adds a new nonhormonal option to the menopausal hot flash management toolbox...

Weave AI Into Your Plan for Precepting Learners

Preceptors are asking for advice on how to use artificial intelligence (AI) during learning experiences with residents and students...

GO TO FULL ISSUE

CE & Training

NEW REQUIRED COURSE: Pet Meds Unleashed: Keeping Our Furry Patients Safe

CME-IN-THE-LETTER: Prescriber Insights January 2026

LIVE CE: Antimicrobial Stewardship: Putting Principles into Practice

PODCAST CE: Rumor vs Truth - GLP-1 Side Effects

GO TO CE & TRAINING ORGANIZER

Featured Clinical Resources

GLP-1 and GIP/GLP-1 Receptor Agonists interactive chart

Stay current with Prescriber Insights

Evidence-based updates, prescribing pearls, and monthly CE to support confident, informed therapy decisions. Learn more

Group Purchases & Pricing

Prescriber Insights is eligible for bulk discounts. Customize CE and compliance training assignments. Easily manage users and run reports. Bundle with other products for significant savings. Request information

GO TO FULL PODCAST >